about
Development of Companion DiagnosticsNuclear imaging of the breast: translating achievements in instrumentation into clinical useMolecular imaging agents: impact on diagnosis and therapeutics in oncologyThe preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients.Can positron emission tomography/computed tomography with the dual tracers fluorine-18 fluoroestradiol and fluorodeoxyglucose predict neoadjuvant chemotherapy response of breast cancer?--A pilot study.Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.Pharmacodynamic imaging guides dosing of a selective estrogen receptor degraderTargeting lysyl oxidase for molecular imaging in breast cancer.PET Tracers for Clinical Imaging of Breast Cancer.Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.Oestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FESComparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLTQuantitative multimodality imaging in cancer research and therapyFrontiers of Biomedical Imaging Science 2009: workshop report and research opportunities.Automated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer.Asymmetric 18F-fluorination for applications in positron emission tomography.PET/CT and breast cancer subtypes.High specific activity is not optimal: 18 F-fluoroestradio positron emission tomography-computed tomography results in a breast cancer xenograft.Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy.Organomediated Enantioselective (18)F Fluorination for PET Applications.
P2860
Q26774670-D8CB4D14-69B0-408E-A3F8-298F11653FC8Q30419180-D0A4526C-072F-489B-8A0F-0286D70B5C09Q30433423-5B57E355-E4B3-4C49-A9FF-C08CBDBAF6BCQ35009047-2D1286A2-629D-498B-8808-E22E9869F495Q35036174-CD4218EB-BEEA-418F-B815-D29DA6B8EC76Q35143049-B1417710-7B9B-42C8-8E87-74DA2EE3603AQ35178385-3331F5AE-908D-48BB-A3FA-78D56EAA4A7DQ35945328-54270B08-2583-4260-92EB-E2624C26E6D2Q36221080-B7DDFD3A-486F-4CFF-858C-78423C1984AEQ36325275-B3636947-46F6-4B39-9578-FC717AB293D9Q36326057-929944AC-8945-4E2D-832F-07C074822C10Q36338316-46E5A127-4E8A-4C8D-BF38-4E4D2F51FD72Q37007810-4AC02F18-12EF-47AD-ACFF-7DA4624926FAQ37389698-4ABFEE35-746A-4E36-AF98-30870B3B7D49Q37722894-A3863A98-4BE9-4BED-8BE5-D7FB70B4D0C8Q41174141-4316B9EF-AB66-46E8-A78A-ED4F827B8D8AQ46806270-7525027D-42EB-4F98-8917-2AB21EDBC57DQ48301796-B946BD3E-91B3-44CB-A138-43A651ABD94EQ51311647-20F8EF9E-0F8A-4731-911D-E1C55ECBC85BQ52991000-1B0F9BEB-E777-4F35-B622-1C11A8322D90
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
18F-Fluoroestradiol.
@en
type
label
18F-Fluoroestradiol.
@en
prefLabel
18F-Fluoroestradiol.
@en
P2093
P1476
18F-Fluoroestradiol.
@en
P2093
David A Mankoff
Hannah M Linden
Jeanne M Link
Kenneth A Krohn
Lavanya Sundararajan
P304
P356
10.1053/J.SEMNUCLMED.2007.08.003
P577
2007-11-01T00:00:00Z